The effectiveness of high-dose adjunctive corticosteroid therapy in HIV-negative patients with Pneumocystis jirovecii pneumonia

Key Points

• Adjunctive therapy may not need high doses for effective treatment.
• Findings suggest treatment efficacy with lower doses of corticosteroids.
• Study focuses on HIV-negative individuals suffering from Pneumocystis jirovecii pneumonia.
• Lowering corticosteroid dosage may reduce treatment risks and side effects.